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Increased Migration of Murine Keratinocytes Under Hypoxia
Is Mediated by Induction of Urokinase Plasminogen Activator
Richard J. Daniel and RichardW. Groves
Center for Dermatology, Department of Medicine, University College London, UK
One of the key consequences of cutaneous wounding is
the development of tissue hypoxia. Recent data have
suggested that this is a potent stimulus for increased
keratinocyte migration and hence re-epithelialization,
although the mechanisms responsible for this remain
unclear. In this study we have investigated the relation-
ship between hypoxia, plasminogen activation, and in
vitro wound healing. Exposure of keratinocyte cultures
to hypoxia resulted in upregulation of urokinase
plasminogen activator mRNA and a subsequent in-
crease in urokinase plasminogen activator-mediated
plasminogen activation, as determined by indirect
chromogenic peptide assay and plasminogen-linked
zymography. Analysis of keratinocyte wound healing
in vitro con¢rmed enhanced wound closure in hypoxic
cultures compared with normoxic cultures after 16 h.
Pretreatment of normoxic and hypoxic cultures with
mitomycin C and cytochalasin B indicated that in
this system wound closure was due to keratinocyte
migration rather than proliferation. Addition of the
broad-spectrum serine proteinase inhibitor, p-amino-
benzamidine, or the speci¢c urokinase plasminogen
activator inhibitors, amiloride and WX-293, signi¢-
cantly reduced wound closure in hypoxic cultures and
abrogated the hypoxic enhancement of wound closure.
These data indicate a central role for urokinase plasmi-
nogen activators in hypoxic keratinocyte migration
and suggest a potential mechanism for enhanced re-
epithelialization of wounds under low oxygen tensions.
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C
utaneous wounding is characterized by a dramatic
sequence of cellular changes that result in the trans
formation of basal keratinocytes to motile cells, a
process that is essential for re-epithelialization. This
wound-activated response involves increased levels
of in£ammatory cytokines and growth factors, altered keratin
and integrin expression, and induction of proteolytic enzymes,
including matrix metalloproteinases (MMP) and plasminogen
activators (reviewed in Martin, 1997). Re-epithelialization, result-
ing from increased keratinocyte migration and proliferation, is a
key feature of normal cutaneous tissue repair and studies from
transgenic and knockout mice indicate that an intact plasminogen
activator/plasmin system is required for normal wound healing
(Bugge et al, 1996; Romer et al, 1996).
In cutaneous tissue the predominant plasminogen activator is
urokinase plasminogen activator (uPA) ( Jensen et al, 1988). uPA
is a 45 kDa glycoprotein, initially secreted as an inactive pro-en-
zyme, which binds to a speci¢c receptor (uPAR) and is activated
by proteolytic cleavage (Cubellis et al, 1986; Petersen et al, 1988).
Receptor binding of uPA is not essential for proteolytic function,
as uPA is equally e⁄cient at plasminogen activation when
membrane-anchored (Lee et al, 1992) or in a nonreceptor-bound
soluble form (Wilhelm et al, 1994; Carmeliet et al, 1998). Once
activated, uPA converts the ubiquitous zymogen plasminogen to
plasmin, a broad range proteolytic enzyme that facilitates matrix
degradation, stimulates growth factor precursors, and activates
several prometalloproteinases (Mignatti et al, 1996; Carmeliet
et al, 1997, 1998).
Throughout the last decade, evidence for involvement of uPA
in cellular migration and proliferation has accumulated. Overex-
pression of uPA and increased uPA-mediated plasminogen acti-
vating activity have been observed in migrating monocytes,
endothelial cells, and keratinocytes in culture (Morioka et al,
1987; Pepper et al, 1993). In a variety of cell types uPA has been
associated with promotion of migration either by uPA-mediated
proteolytic activity (Wijnberg et al, 1997), by signal transduction
pathways triggered by uPA/uPAR association with integrins
(Carriero et al, 1999; Nguyen et al, 1999; Yebra et al, 1999), or by a
direct chemotactic e¡ect (Fazioli et al, 1997; Poliakov et al, 1999). In
addition, in vivo analyses of both mouse and human healing
wounds have shown increases in uPA mRNA and plasminogen-
activating activity (Grondahl-Hansen et al, 1988; Romer et al, 1991;
Schaefer et al, 1994), as well as identifying uPA as a positive regu-
lator of epidermal proliferation (Hibino et al, 1999; Jensen and
Lavker, 1999). These ¢ndings suggest that uPA, and its association
with uPAR, may play an important part in the migration and
extracellular matrix invasion required for normal wound healing.
A major physiologic consequence of vascular disruption and
tissue damage in wounded skin is hypoxia (Niinikoski et al, 1972;
Chang et al, 1983). In vivo, acute hypoxia has been suggested to
regulate enhanced wound re-epithelialization (Winter, 1962;
Alvarez et al, 1983;Woodley and Kim, 1992), although long-term
hypoxia may contribute to impaired wound repair (Stadelmann
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et al, 1998). In vitro, human keratinocyte migration is increased un-
der hypoxic conditions (O’Toole et al, 1997), and hypoxia is
known to regulate expression of MMP, such as MMP-9, and
components of the plasminogen activation/plasmin system, in-
cluding uPAR and PAI-1, in a wide variety of cell types (O’Toole
et al, 1997; Pinsky et al, 1998; Graham et al, 1999). At present, how-
ever, no data exist concerning the functional consequences of hy-
poxia on uPA-mediated plasminogen activation in keratinocytes.
We have therefore investigated the role of hypoxia in the
regulation of keratinocyte-derived uPA and, using a series of
speci¢c inhibitors of uPA activity, have evaluated the role of
uPA in hypoxia-enhanced keratinocyte migration. Our ¢ndings
demonstrate that hypoxia is a profound regulator of both uPA
mRNA and functional protein in keratinocytes, and that hypoxic
enhancement of keratinocyte migration is blocked in the presence
of uPA inhibitors. These results suggest that the enhanced kerati-
nocyte migration following hypoxia is mediated by hypoxic
induction of uPA.
MATERIALS AND METHODS
Reagents The plasmin-speci¢c chromogenic substrate H-D-valyl-L-
leucyl-L-lysine-p-nitroanilide dihydrochloride (S-2251), human plasmino-
gen, and plasmin were from Chromogenix (Milan, Italy). Human
urokinase was purchased from Calbiochem (Nottingham, U.K.). Running
bu¡er, renaturing bu¡er, developing bu¡er, and colloidal blue staining kit
used for zymographic analysis were all supplied by Novex (Carlsbad, NM).
Protease inhibitors, amiloride and p-aminobenzamidine were purchased
from Sigma (Poole, U.K.). The selective uPA inhibitor, WX-293 (Sperl
et al, 2000) was a kind gift of Dr KatjaWosikowski (Wilex Biotechnology
GmbH, Munich, Germany). The pDB1519 vector (GenBank accession no.
X02389) containing the complete murine uPA cDNAwas purchased from
the American Type Culture Collection (ATCC no. 63256). 32P-radiolabeled
nucleotides were purchased from Amersham Pharmacia (Little Chalfont,
U.K.).
Cell culture PAM 212 murine keratinocytes (a kind gift of Dr S. Yuspa,
Bethesda, MD) were maintained in RPMI 1640 medium supplemented
with 10% newborn calf serum, glutamine, penicillin/streptomycin, and
HEPES (all supplied by Gibco BRL, Paisley, U.K.). At approximately
60% con£uence, medium was aspirated, cultures were washed twice and
refreshed with serum-free RPMI 1640 medium. Serum-free conditions
were necessary on account of the plasminogen activating activity
constitutively present in newborn calf serum. After 24 h incubation in
normoxic conditions, cultures were washed, refreshed again with serum-
free medium, and maintained for an additional 24 h under the same
conditions or made hypoxic by incubation in sealed Billups Rothenburg
chambers £ushed with 1% O2, 5% CO2, and 94% N2. Culture £uid O2
tensions assessed after 24 h, using an ABL4 analyzer (Radiometer,
Copenhagen, Denmark), were 2.7370.12% (mean7SEM).
Keratinocyte viability assays Cell viability was measured by Trypan
blue exclusion and lactate dehydrogenase (LDH) release. LDH release was
measured using an in vitro toxicology kit (Sigma), according to the
manufacturer’s instructions, and calculated as a percentage of total LDH
released following detergent-mediated disruption of all cells.
Indirect chromogenic peptide assay for uPA activity Plasminogen
activation in supernatants was measured using an indirect chromogenic
peptide assay (Reinartz et al, 1993). Cell supernatants were harvested and
total protein levels measured using a modi¢ed Bradford protein assay,
according to the manufacturer’s instructions (Promega, Southampton,
UK). 60 ml samples, containing equal amounts of total protein, were
incubated with 20 ml of S-2251 (2 mg per ml) in 96-well plates for 10
min at 371C. Twenty microliters of human plasminogen (0.4 mg per ml)
was added to each well, and plates incubated at 371C for the duration of the
experiment. Parallel samples incubated with 0.1 mM amiloride (a speci¢c
uPA inhibitor) were assayed to determine the role of uPA in any detected
plasminogen activation. Color change was analyzed every 20 min at
405 nm. Rate of change of absorbance at 405 nm against time was
calculated from sample readings (corrected for amiloride) and uPA values
(IU per ml) determined by comparison with a human urokinase
(Calbiochem) standard curve.
Plasminogen-linked zymography Supernatant samples were equa-
lized for total protein prior to separation at 41C on denaturing sodium
dodecyl sulfate^polyacrylamide gel electrophoresis gels, containing 0.2%
b-casein (Sigma) and 15 mg human plasminogen per ml. Proteins were
renatured in renaturing bu¡er washes (2 20 min), and reactions
developed by incubation in developing bu¡er overnight. Gels were
incubated with colloidal blue stain and caseinolytic activity was detected
as clear bands against the blue-stained casein background. Murine urine, a
rich source of uPA, was used as positive control.
Probes cDNA probes for uPA were prepared by polymerase chain
reaction ampli¢cation of a 437 bp fragment from pDB1519, containing
murine uPA cDNA. Primers used were AATGTGCACAGCCAT-
CCAGGT for sense, and CCTCAGCTACCTGAGGGCCAT for anti-
sense. Probes were labeled using a 32P-deoxycytidine triphosphate
oligolabeling kit (Amersham Pharmacia) according to the manufacturer’s
instructions. 32P-uridine triphosphate-labeled anti-sense riboprobes for
uPARwere prepared from a murine uPAR cDNA plasmid (a kind gift of
Dr F. Lupu, Thrombosis Research Institute, London, U.K.) by reverse
transcription using the MAXIscript SP6/T7 kit (Ambion, Austin, TX)
according to the manufacturer’s instructions.
RNA analysis Total keratinocyte RNA was extracted using Trizol
reagent (Gibco) according to the manufacturer’s instructions. RNA was
resuspended in RNAase-free water, and nucleic acid concentration
determined by spectrophotometric analysis at 260 nm. Ten microgram
total RNA samples were size fractionated on 1% agarose gels containing
6.3% formaldehyde. Following transfer to Hybond Nþ membranes, RNA
was ¢xed by ultraviolet cross-linking and probed with the uPA or uPAR
probe. After washing under stringent conditions, membranes were
exposed to autoradiography ¢lm. Densitometry was performed following
scanning of autoradiographs, with equal loading determined by analysis of
28 S RNA.
In vitro wounding In vitro wounding was performed using a modi¢ed
version of the scratch assay described previously (Cha et al, 1996). PAM
212 keratinocytes were grown to con£uence in six-well dishes, and after a
single wash in serum-free medium, monolayers were scratched with a
plastic pipette tip creating a cell-free area (‘‘wound’’) approximately 2 mm
in width. Cultures were washed twice in serum-free medium to remove
cell debris and a marked area of the wound was photographed under
phase-contrast microscopy. Cultures were covered with serum-free
medium, and uPA inhibitors added to relevant wells before incubation
under normoxic or hypoxic conditions. Previous experiments had
demonstrated that these inhibitors, at appropriate concentrations, did not
a¡ect keratinocyte viability and did not induce a proliferative response
(data not shown). After a speci¢c incubation period the marked area of
the wound was re-photographed and wound area recovered (mm2) was
determined by analysis performed on a Macintosh computer using the
public domain NIH Image program (developed at the U.S. National
Institutes of Health and available on the Internet at http://rsb.info.nih.gov/
nih-image/).
RESULTS
PAM 212 keratinocyte viability is una¡ected after 24 h
culture under hypoxic conditions To determine whether
PAM 212 keratinocytes could be cultured under low oxygen
conditions for prolonged periods without signi¢cant loss of
viability, cells were maintained in normoxic and hypoxic
conditions for 24 h and assessed for LDH release and Trypan
Blue exclusion. Cells cultured under hypoxic conditions showed
no variation in cell morphology at the light microscope level (not
shown). Trypan Blue exclusion and LDH release analysis showed
no signi¢cant di¡erence between normoxic and hypoxic samples
(Table I). In addition, no signi¢cant di¡erence was seen in the
pH value of conditioned medium from normoxic and hypoxic
cultures (Table I).
Upregulation of uPA and uPAR mRNA, and increased
levels of functional uPA protein are observed in PAM 212
keratinocytes cultured under hypoxic conditions To
investigate the e¡ect of hypoxia on keratinocyte expression of
uPA and uPAR mRNA, total RNA was prepared from cells
cultured under normoxic or hypoxic conditions for 24 h and
analyzed by northern blot analysis. Both uPA and uPAR
mRNA were easily detected in resting keratinocytes as has
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previously been described (Schaefer et al, 1996), and both signals
were induced approximately 2-fold following 24 h hypoxia
(Fig 1). To determine whether there was concomitant induction
of uPA protein, conditioned medium from keratinocytes cultured
under normoxic or hypoxic conditions for 24 h was assayed for
plasminogen activating activity. Plasminogen activation was
detectable in both normoxic and hypoxic samples and could
be almost entirely inhibited (496% inhibition) by the addition
of 0.1 mM amiloride, indicating that this was uPA mediated. As
shown in Fig 2(A), a 4 -fold increase in uPA activity was
observed in hypoxic compared with normoxic samples.
Moreover, plasminogen-linked zymography detected a band of
b-casein degradation corresponding to murine uPA (E45 kDa)
that was markedly increased in hypoxic conditioned medium
(Fig 2B) con¢rming that the increased plasminogen activating
activity is uPA mediated.
Hypoxia enhances in vitro wound closure in PAM 212
keratinocytes by increased cell migration Under normoxic
conditions, wound closure of 0.16970.017 mm2 was observed
at 16 h (Fig 3A,C). Under hypoxic conditions, signi¢cantly
increased wound closure was observed (0.2770.005 mm2)
amounting to a 59.872.8% (mean7SEM, po0.01) enhance-
ment (Fig 3B,D). To determine the mechanism involved, cells
were treated with cytochalasin B, a potent inhibitor of cell
migration, or mitomycin C, a potent inhibitor of cellular
proliferation. Keratinocyte monolayers were wounded as
described, and cultured under normoxic and hypoxic conditions
for 24 h. Inhibition of migration by cytochalasin B almost
completely prevented wound closure (mean o9% of control)
in both normoxic and hypoxic cultures (Fig 4), indicating
that hypoxic-enhanced wound closure is dependent on cell
migration. Moreover, inhibition of keratinocyte proliferation by
mitomycin C had no signi¢cant e¡ect on wound area recovered
over a 24 h period (Fig 4), indicating that cellular proliferation is
not required for enhancement of wound closure under hypoxic
conditions. These observations are consistent with previous data
demonstrating that, in vitro, primary human keratinocyte wound
closure is dependent on migration and not proliferation
(Morioka et al, 1987).
Hypoxia enhances in vitro wound closure by PAM 212
keratinocytes as a result of induction of uPA Having
demonstrated upregulation of functional uPA in hypoxic
Table I. Viability of PAM 212 Keratinocytes cultured under
normoxic and hypoxic conditions
h Normoxia Hypoxia p (Student t-test)
Trypan Blue exclusiona 24 7.071.2 8.170.6 0.41
LDH assayb 24 7.271.9 9.671.8 0.24
pHc 24 7.370.05 7.470.06 0.34
a,bData expressed as percentage cell death (mean7SEM).
cData are expressed as pH units7SEM.
a,b,cData shown are from triplicate wells in 4 independent experiments.
Figure1. Hypoxia increases uPA and uPAR mRNA levels. RNA
was extracted from PAM 212 keratinocyte cultures maintained in nor-
moxic (N) or hypoxic (H) conditions for 24 h. Northern blot analysis
showed an approximately 2-fold increase in both uPA and uPAR
mRNA in cells cultured under hypoxic conditions. Densitometry data
(mean7SEM) are from three independent experiments expressed as a
percentage of normoxic control (100%) after correcting for loading.
Figure 2. Hypoxia increases levels of uPA-mediated plasminogen
activation activity in PAM 212 keratinocyte conditioned medium.
Conditioned medium from PAM 212 keratinocyte cultures maintained in
normoxic (N) and hypoxic (H) conditions for 24 h was assayed for uPA
activity. (A) S-2251 indirect chromogenic peptide assay showed a 4-fold
increase of uPA levels in cells cultured under hypoxic conditions. Data
shown (mean7SEM) are from triplicate wells in four independent experi-
ments. (B) Plasminogen-linked zymography revealed a marked increase in
intensity of a 45 kDa band, corresponding to murine uPA, in hypoxic sam-
ples compared with normoxic samples. Data shown is representative of
three independent experiments.
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keratinocytes, we were interested to determine whether this
played a part in the enhancement of in vitro wound closure
observed under hypoxia. Thus, PAM 212 keratinocyte mono-
layers were wounded as described and maintained with or
without addition of uPA inhibitors. In control cultures, the area
recovered over 16 h was increased by 67.0778.7% (mean7SEM)
in hypoxic conditions compared with normoxic conditions.
Following addition of amiloride, a selective inhibitor of
urokinase (Vassalli and Belin, 1987), the hypoxia induced
enhancement of wound closure was completely abolished,
however, and no signi¢cant di¡erence in wound area recovered
could be observed between normoxic and hypoxic cultures
(Fig 5A). No e¡ect of amiloride was observed on wound
closure under normoxic conditions, suggesting that uPA does
not play a major part in this situation. Presence of the broad-
spectrum proteinase inhibitor, p-aminobenzamidine, however,
signi¢cantly reduced wound area recovered in both normoxic
and hypoxic cultures (Fig 5B), suggesting that proteases other
than uPA may be relevant in normoxic wound closure. Finally,
we employed WX-293, a recently described highly selective
inhibitor of uPA activity (Sperl et al, 2000). At 0.2 mM,WX-293
completely inhibited hypoxic enhancement of wound closure,
whereas at 0.1 mM there was 70% inhibition, suggesting a
concentration-related e¡ect (Fig 5C). Furthermore, the addition
of 0.1 mM and 0.2 mM WX-293 resulted in a 55.372.5% and
74.0773.05% inhibition of uPA, respectively, indicating a direct
correlation between uPA inhibition and abrogation of hypoxia-
mediated wound closure. Interestingly, like amiloride and in
contrast to p-aminobenzamidine, no e¡ect of WX-293 on the
wound area recovered in normoxic cultures was observed
(Fig 5C). Taken together, these data indicate that the enhanced
wound closure seen under hypoxic conditions relies on release
of functional uPA by keratinocytes, and also suggests that
proteases other than plasminogen activators may play a part in
keratinocyte migration under normoxic conditions.
DISCUSSION
Acute cutaneous wounds are characterized by the rapid develop-
ment of hypoxia secondary to interruption of normal vasculature
and the development of a ¢brin clot. Cells local to the wound
must be able to adapt appropriately to this hypoxic environment
such that wound healing progresses as rapidly as possible. The
data presented here suggest that hypoxia is a potent stimulus for
keratinocyte migration and indicate that the likely mediator of
this response is uPA.
Hypoxic regulation of the plasminogen activator/plasmin sys-
tem has been documented in several cell types (Fitzpatrick and
Graham, 1998; Graham et al, 1998; Maity and Solomon, 2000),
and this study has demonstrated that hypoxia is a potent regulator
of keratinocyte plasminogen activation in vitro. Both uPA and
uPAR mRNA were induced after 24 h exposure to hypoxia
and there was a marked induction of uPA-mediated proteolytic
activity in cell culture supernatants following hypoxic stimula-
tion. This ¢nding contrasts with the e¡ects of hypoxia in other
tissues, such as in lung, trophoblast, and endothelial cells, hypoxia
causes a decrease in soluble plasminogen activation (Pinsky et al,
1998). Interestingly however, there is increased cell-associated
Figure 3. Hypoxia enhances in vitro wound closure. PAM 212 kerati-
nocyte monolayers were wounded as described, and incubated under nor-
moxic (A,C) or hypoxic (B,D) conditions. Wounds were photographed
under phase-contrast microscopy at 0 h (A,B) and 16 h (C,D). Photographs
shown are representative of four independent experiments. Under nor-
moxic (N) conditions wound closure of 0.16970.017 mm2 was observed.
Under hypoxic (H) conditions signi¢cantly increased wound closure of
0.2770.005 mm2 was observed amounting to a 59.872.8% (mean7SEM)
enhancement in cultures incubated under hypoxic conditions compared
with normoxic conditions (E). Data shown are from four independent ex-
periments. npo0.01 (signi¢cant from normoxia).
Figure 4. In vitro wound closure is dependent on keratinocyte
migration. PAM 212 keratinocytes monolayers were treated with mito-
mycin C or cytochalasin B for 4 h and wounded as described. Cultures
were then incubated in serum-free RPMI containing cytochalasin B or
serum-free RPMI alone (mitomycin C pretreated monolayers), under nor-
moxic (N) and hypoxic (H) conditions for 24 h. Image analysis of wound
area recovered (mm2) indicated a marked inhibition in cytochalasin B-trea-
ted cultures under both normoxic and hypoxic conditions, whereas no sig-
ni¢cant di¡erence was observed between mitomycin C-treated and control
cultures in both normoxic and hypoxic conditions. Data shown
(mean7SEM) are from three independent experiments.
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plasminogen activation in these cells, resulting from elevated cell
surface expression of uPAR (Graham et al, 1998, 1999). These dif-
ferences between keratinocytes and other cell types likely re£ect
the di¡ering requirements for regulation of plasminogen activa-
tion in di¡erent tissues, with di¡use plasminogen activation re-
sulting from soluble uPA being appropriate in the setting of
acute cutaneous wounding.
Our data indicate that uPA inhibition by amiloride (Vassalli
and Belin, 1987) andWX-293 (Sperl et al, 2000), and broad range
protease inhibition by p-aminobenzamidine (Geratz and Cheng,
1975), completely blocks hypoxia-mediated enhancement of kera-
tinocyte migration, strongly suggesting that the presence of func-
tional uPA is required for increased keratinocyte migration under
hypoxic conditions. Interestingly, whereas the selective uPA inhi-
bitors, amiloride and WX-293, had no e¡ect on wound closure
under normoxic conditions, inhibition of serine proteinase activ-
ity by p-aminobenzamidine reduced the wound area recovered in
normoxic cultures, suggesting that non-uPA-mediated, broad-
spectrum protease activation may play a part in keratinocyte
migration under normoxic conditions.
Our observation that hypoxia mediates an increase in keratino-
cyte migration by regulation of uPA provides the ¢rst evidence of
a role for the plasminogen activator/plasmin system in hypoxic
keratinocyte migration. Much emphasis has been placed on the
role of MMP’s in cellular motility (Saarialho-Kere et al, 1993; In-
oue et al, 1995; Pilcher et al, 1997; Makela et al, 1999), with migrat-
ing keratinocytes overexpressing type I and type IV collagenases
(Sarret et al, 1992; Pilcher et al, 1997). Previous studies of migration
of human keratinocytes under hypoxia demonstrated upregula-
tion of MMP-9 (O’Toole et al, 1997), although functional evi-
dence for a role for this protease in keratinocyte migration
is awaited. Interestingly, several MMP’s, including MMP-2
and MMP-9, can be activated by uPA-generated plasmin in vitro
(Mazzieri et al, 1997; Carmeliet et al, 1998). Furthermore, uPA-
mediated MMP-9 activation was recently implicated in bronchial
epithelial cell migration (Legrand et al, 2001), suggesting that hy-
poxic induction of uPA may be a proximal step in the induction
of these proteases by hypoxia. The resulting increase in levels of
both plasmin and active MMP following hypoxia could encou-
rage rapid dissolution of the extracellular matrix thereby facilitat-
ing keratinocyte migration and enhancing wound closure.
Although our data suggest that uPA-mediated plasminogen ac-
tivation promotes keratinocyte motility in vitro, the exact molecu-
lar mechanisms underlying this remain unclear. Recent data
indicate that uPA-mediated cell migration can occur in the ab-
sence of uPA-speci¢c proteolytic activity suggesting alternative,
nonproteolytic roles for this molecule in the regulation of cell
migration. One possibility is that uPA has a chemotactic e¡ect
on hypoxic keratinocytes. The chemotactic properties of uPA on
other cell types in culture are well documented and are generally
reliant on uPA/uPAR binding (Resnati et al, 1996; Fazioli et al,
1997). Recent data, however, showed uPA was chemotactic for
vascular smooth muscle cells after mutation of the catalytic
domain and removal of the growth factor-like domain, used for
uPAR binding (Poliakov et al, 1999). These ¢ndings indicate that
the nonproteolytic chemotactic e¡ect of uPA can function both
in the presence and independently of uPAR.
Thus, although the data presented is limited to a murine kera-
tinocyte cell line, necessitating further studies to extend the ob-
servations to a human system, and the exact mechanism by
which uPA regulates hypoxic keratinocyte migration is uncertain,
the inhibition of enhanced migration by uPA inhibitors shown in
this study indicates that uPA may play a signi¢cant part in regu-
lating keratinocyte migratory responses in a hypoxic environ-
ment. Despite long-term hypoxia being an impediment to
normal wound healing, migration of keratinocytes is critical for
Figure 5. Inhibition of uPA activity abrogates
hypoxia-mediated enhancement of in vitro
wound closure. PAM 212 keratinocyte monolayers
were wounded and incubated under normoxic (N)
or hypoxic (H) conditions, with or without the ad-
dition of amiloride (A), p-aminobenzamidine (B),
or the selective uPA inhibitor,WX-293 (C). Image
analysis of wound area recovered (mm2) indicated
that the addition of uPA inhibitors suppressed hy-
poxic enhancement of in vitro wound closure to a
level equal to or below that observed in cells cul-
tured under normoxic conditions. Data shown
(mean7SEM) are from three independent ex-
periments. npo0.01 (signi¢cantly from normoxia),
ns¼ p40.05 (not signi¢cantly from normoxia).
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e¡ective wound repair and modulation of tissue responses to the
early stages of hypoxia may prove a powerful means of accelerat-
ing wound closure in therapeutic situations.
This study was supported by P¢zer Central Research, Sandwich, UK
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